Bleichroeder’s Kazia Therapeutics KZIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.71M Buy
490,410
+90,410
+23% +$1.13M 0.46% 47
2026
Q2
$5.63M Hold
400,000
– – 1.01% 15
2026
Q1
$2.98M Hold
400,000
– – 0.51% 27
2025
Q4
$2.76M Buy
+400,000
New +$3.41M 0.49% 27

Other funds holding KZIA

Bleichroeder's KZIA Position: Q3 2026 in Review

Bleichroeder increased its Kazia Therapeutics (KZIA) stake by 23% in Q3 2026, buying an estimated $1.13M and bringing the position to 490,410 shares worth $4.71M. The position accounts for 0.46% of the portfolio, ranked #47.

Bleichroeder first reported a position in KZIA in Q4 2025 and has held it in 4 quarters since. The position peaked at $5.63M in Q2 2026. 34 funds tracked by Wall St. Rank hold KZIA as of Q3 2026.

  • Bleichroeder held 490,410 shares of Kazia Therapeutics worth $4.71M as of Q3 2026.
  • Bleichroeder bought 90,410 Kazia Therapeutics shares in Q3 2026, an estimated $1.13M.
  • Kazia Therapeutics made up 0.46% of Bleichroeder's portfolio in Q3 2026, its #47 holding.
  • Bleichroeder first reported a position in Kazia Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Bleichroeder's Kazia Therapeutics position peaked at $5.63M in Q2 2026.
  • 34 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2026.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.